Quercetin was extracted from Portulaca oleracea L. through biphasic
acid hydrolysis to investigate its potential as a suppressor of
dipeptidyl peptidase IV (DPP-IV) and its
hypoglycemic effect in type 2 diabetic mice. The extraction procedure was optimized utilizing the response surface method (RSM) in a single-factor experimental setting. An extraction efficiency of 0.675% was achieved using the following optimized parameters: 0.064 mol/L vitriol, 1 : 109.155 solid-liquid ratio, and 21.408 min ultrasonication. Overall, findings indicate the effectiveness of
quercetin extraction. A mouse model for
type 2 diabetes was established to receive oral treatment with various
quercetin concentrations for 8 weeks. Fasting
blood glucose (FBG) and the DPP-IV activity in the serum were significantly reduced. The weight and
insulin levels of the mice in the
quercetin group were raised compared to those in the model group (P < 0.01).
Quercetin dose-dependently inhibited postprandial
blood glucose excursions, as demonstrated by the oral
glucose tolerance test. These results confirmed that
quercetin has
hypoglycemic effects and considerably improves
insulin sensitivity via DPP-IV targeting.